Eiger BioPharma: Q2 Earnings Snapshot
In this article:
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Eiger BioPharmaceuticals Inc. (EIGR) on Monday reported a loss of $20.7 million in its second quarter.
The Palo Alto, California-based company said it had a loss of 47 cents per share.
The biopharmaceutical company posted revenue of $4.6 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR
